Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Darmkanker vaker ontdekt in vroeg stadium, minder operaties en betere overleving
mrt 2024 | Maag-darm-leveroncologie